Joshua Bogus

The safety of double- and triple-drug community mass drug administration for lymphatic filariasis: A multicenter, open-label, cluster-randomized study

Gary J. Weil, Joshua Bogus, Michael Christian et al. · PLoS Medicine · 2019 · 95 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Barriers to Accessing Emergency Medical Services in Accra, Ghana: Development of a Survey Instrument and Initial Application in Ghana

Nee‐Kofi Mould‐Millman, Sarah Rominski, Joshua Bogus et al. · Global Health Science and Practice · 2015 · 55 citations · Full text

Health Professions, Emergency Medical Services, Emergency Medicine +17

Safety and efficacy of co-administered diethylcarbamazine, albendazole and ivermectin during mass drug administration for lymphatic filariasis in Haiti: Results from a two-armed, open-label, cluster-randomized, community study

Christine Dubray, Anita D. Sircar, Valéry Madsen Beau De Rochars et al. · PLoS neglected tropical diseases · 2020 · 34 citations · Full text

Public Health, Infectious Diseases, Pharmacotherapy +16

A multicenter, community-based, mixed methods assessment of the acceptability of a triple drug regimen for elimination of lymphatic filariasis

Alison Krentel, Nandha Basker, Madsen Beau de Rochars et al. · PLoS neglected tropical diseases · 2021 · 33 citations · Full text

Pharmacy, Community Medicine, Infectious Diseases +17

An open label, randomized clinical trial to compare the tolerability and efficacy of ivermectin plus diethylcarbamazine and albendazole vs. diethylcarbamazine plus albendazole for treatment of brugian filariasis in Indonesia

Taniawati Supali, Yenny Djuardi, Michael Christian et al. · PLoS neglected tropical diseases · 2021 · 26 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17